文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer.

作者信息

Shetty Shishir, Lujambio Amaija, Tacke Frank

机构信息

Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Birmingham, United Kingdom.

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

出版信息

Front Immunol. 2021 Jun 2;12:707329. doi: 10.3389/fimmu.2021.707329. eCollection 2021.

DOI:10.3389/fimmu.2021.707329
PMID:34149741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8208027/
Abstract
摘要

相似文献

[1]
Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer.

Front Immunol. 2021-6-2

[2]
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.

J Immunother Cancer. 2019-10-18

[3]
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy.

Front Immunol. 2024

[4]
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.

Front Immunol. 2021

[5]
The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma.

Int J Mol Sci. 2024-5-21

[6]
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy.

Front Immunol. 2025-4-25

[7]
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.

Gut. 2019-3-22

[8]
New generation cancer therapy: right direction for sure with some uncertainty.

Hepatol Int. 2019-1

[9]
Immune-based therapies for hepatocellular carcinoma.

Oncogene. 2020-3-10

[10]
Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.

World J Gastroenterol. 2018-8-21

引用本文的文献

[1]
A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma.

Evid Based Complement Alternat Med. 2022-9-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索